On July 8, 2021 Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO (gNO) for the treatment of solid tumors, reported that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, is scheduled to participate in two upcoming virtual investor conferences in July 2021 (Press release, Beyond Air, JUL 8, 2021, View Source [SID1234584753]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details for Upcoming Conferences:

Event: Ladenburg Thalmann Annual Healthcare Conference 2021
Date and Time: July 13-14, 2021
Participation: Management will participate in a virtual fireside chat that is scheduled for Tuesday, July 13th at 3:30 PM ET, as well as 1-on-1 meetings virtually

Event: William Blair’s Biotech Focus Conference 2021
Date and Time: July 14-15, 2021
Participation: Management will be available for 1-on-1 meetings virtually

Please contact your representative at either Ladenburg Thalmann or William Blair to schedule a virtual one-on-one meeting with Beyond Air during the respective conference.